title: The relationship between dose and duration of action of intravenous flumazenil in reversing sedation induced by a continuous infusion of midazolam.
authors.affiliation: Hoffmann-La Roche Clinical Pharmacology Unit, Newark Beth Israel Medical Center, New Jersey.
authors.forename: A W
authors.initials: AW
authors.lastname: Dunton
authors.forename: E
authors.initials: E
authors.lastname: Schwam
authors.forename: V
authors.initials: V
authors.lastname: Pitman
authors.forename: P
authors.initials: P
authors.lastname: Leese
authors.forename: J
authors.initials: J
authors.lastname: Siegel
mesh_terms: D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D005442:Flumazenil / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008874:Midazolam / Q000494:pharmacology*; D011963:Receptors, GABA-A / Q000378:metabolism*; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
chemical_list: D011963:Receptors, GABA-A; D005442:Flumazenil; D008874:Midazolam